Download PDF
Horm Metab Res 2002; 34(5): 254-259
DOI: 10.1055/s-2002-32139
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

No Direct Link between Albumin Excretion Rate and Insulin Resistance - A Study in Type 1 Diabetes Patients with Mild Nephropathy

M.  Svensson1 , J.  W.  Eriksson1
  • 1Dept. of Medicine, Umeå University Hospital, Sweden
Further Information

Publication History

29 March 2001

24 September 2001

Publication Date:
10 June 2002 (online)

Also available at
    Permissions and Reprints

Abstract

Aims: Albuminuria is thought to be associated with insulin resistance in patients with type 1 and type 2 diabetes as well as in non-diabetic subjects. The aim of this study was to find out about any direct correlation between the albumin excretion rate (AER) and insulin resistance; this was investigated in patients with type 1 diabetes. Methods: Euglycemic hyperinsulinemic clamps were performed in 18 patients with type 1 diabetes and incipient nephropathy - elevated albumin excretion rate (AER > 20 µg/min) but normal glomerular filtration rate (GFR) (81 - 135 ml/min/1.73 m2). Results: AER, determined as mean of two overnight urine collections, was 137 ± 157 (mean ± S.D.) µg/min (range 24 - 447). Insulin sensitivity, expressed as the M-value, was 6.8 ± 2.9 mg/kg/min, insulin sensitivity index (ISI = 100 × M/plasma insulin) 7.9 ± 3.4 and insulin clearance (MCRins) 17.0 ± 4.0 ml/kg/min. Simple regression analyses showed no direct association between AER and M, ISI or MCRins. GFR was not associated with M, ISI or MCRins in this group, either. AER was, however, positively associated with poor glucose control (high HbAlc) and tobacco use. Conclusions: These results suggest that the degree of albuminuria is not directly linked to insulin resistance. This was shown in type 1 diabetics, but could possibly be applicable in other subjects as well.

Key words

Type 1 Diabetes - Albuminuria - Euglycemic Hyperinsulinemic Clamp - Insulin Sensitivity

References

  • 1 Andersen A R, Christiansen J S, Andersen J K, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.  Diabetologia. 1983;  25 496-501
    PubMedGoogle Scholar
  • 2 Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors.  Diabetologia. 1987;  30 144-148
    CrossrefPubMedGoogle Scholar
  • 3 Messent J W, Elliott T G, Hill R D, Jarrett R J, Keen H, Viberti G C. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study.  Kidney Int. 1992;  41 836-839
    CrossrefPubMedGoogle Scholar
  • 4 Mogensen C E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.  N Engl J Med. 1984;  310 356-360
    PubMedGoogle Scholar
  • 5 Yudkin J S, Forrest R D, Jackson C A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.  Lancet. 1988;  2 530-533
    PubMedGoogle Scholar
  • 6 Wiseman M, Viberti G, Mackintosh D, Jarrett R J, Keen H. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus.  Diabetologia. 1984;  26 401-405
    PubMedGoogle Scholar
  • 7 Aurell M, Bjorck S. Determinants of progressive renal disease in diabetes mellitus.  Kidney Int Suppl. 1992;  36 S38-S42
    PubMedGoogle Scholar
  • 8 Sawicki P T, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy.  Diabetes Care. 1994;  17 126-131
    PubMedGoogle Scholar
  • 9 Seaquist E R, Goetz F C, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy (see comments).  N Engl J Med. 1989;  320 1161-1165
    CrossrefPubMedGoogle Scholar
  • 10 Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen E R, Jensen J S, Deckert T, Parving H H. Is diabetic nephropathy an inherited complication ?.  Kidney Int. 1992;  41 719-722
    PubMedGoogle Scholar
  • 11 Quinn M, Angelico M C, Warram J H, Krolewski A S. Familial factors determine the development of diabetic nephropathy in patients with IDDM.  Diabetologia. 1996;  39 940-945
    PubMedGoogle Scholar
  • 12 Viberti G C, Keen H, Wiseman M J. Raised arterial pressure in parents of proteinuric insulin dependent diabetics.  Br Med J (Clin Res Ed). 1987;  295 515-517
    PubMedGoogle Scholar
  • 13 Earle K, Walker J, Hill C, Viberti G. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy.  N Engl J Med. 1992;  326 673-637
    PubMedGoogle Scholar
  • 14 de Cosmo S, Bacci S, Piras G P, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, di Minno G, Giorgino R, Liuzzi A, Viberti G C. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria.  Diabetologia. 1997;  40 1191-1196
    CrossrefPubMedGoogle Scholar
  • 15 Rudberg S, Stattin E L, Dahlquist G. Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients.  Diabetes. 1998;  47 1121-1126
    PubMedGoogle Scholar
  • 16 Roglic G, Colhoun H M, Stevens L K, Lemkes H H, Manes C, Fuller J H. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study (see comments).  Diabet Med. 1998;  15 418-426
    CrossrefPubMedGoogle Scholar
  • 17 Fagerudd J A, Tarnow L, Jacobsen P, Stenman S, Nielsen F S, Pettersson-Fernholm K J, Gronhagen-Riska C, Parving H H, Groop P H. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.  Diabetes. 1998;  47 439-444
    PubMedGoogle Scholar
  • 18 Lindsay R S, Little J, Jaap A J, Padfield P L, Walker J D, Hardy K J. Diabetic nephropathy is associated with an increased familial risk of stroke.  Diabetes Care. 1999;  22 422-425
    CrossrefPubMedGoogle Scholar
  • 19 Fagerudd J A, Pettersson-Fernholm K J, Gronhagen-Riska C, Groop P H. The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus.  Diabetologia. 1999;  42 519-526
    CrossrefPubMedGoogle Scholar
  • 20 Yip J, Mattock M B, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria (see comments).  Lancet. 1993;  342 883-887
    CrossrefPubMedGoogle Scholar
  • 21 Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation (see comments).  Diabet Med. 1998;  15 539-553
    CrossrefPubMedGoogle Scholar
  • 22 Yip J, Mattock M, Sethi M, Morocutti A, Viberti G. Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria (letter).  Lancet. 1993;  341 369-370
    PubMedGoogle Scholar
  • 23 Barnett A H, Bain S C. Microalbuminuria and insulin resistance in diabetes mellitus (comment).  Lancet. 1993;  342 880-881
    CrossrefPubMedGoogle Scholar
  • 24 Yki-Jarvinen H, Koivisto V A. Natural course of insulin resistance in type I diabetes.  N Engl J Med. 1986;  315 224-230
    PubMedGoogle Scholar
  • 25 Makimattila S, Virkamaki A, Malmstrom R, Utriainen T, Yki-Jarvinen H. Insulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction.  J Clin Endocrinol Metab. 1996;  81 707-712
    CrossrefPubMedGoogle Scholar
  • 26 DeFronzo R A, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia.  J Clin Invest. 1981;  67 563-568
    CrossrefPubMedGoogle Scholar
  • 27 DeFronzo R A, Tobin J D, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance.  Am J Physiol. 1979;  237 E214-E223
    PubMedGoogle Scholar
  • 28 Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate.  Scand J Clin Lab Invest. 1981;  41 611-616
    CrossrefPubMedGoogle Scholar
  • 29 Beme C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors.  Diabetes Care. 1991;  14 Suppl 4 39-47
    PubMedGoogle Scholar
  • 30 Eriksson J W, Jansson P A, Foley K, Lithell H. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non- insulin-dependent diabetes mellitus patients.  J Hypertens. 1996;  14 1469-1475
    CrossrefPubMedGoogle Scholar
  • 31 Ahmad J, Siddiqui M A, Ahmad H. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.  Diabetes Care. 1997;  20 1576-1581
    CrossrefPubMedGoogle Scholar
  • 32 Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin R. Essential hypertension is associated with decreased insulin clearance and insulin resistance (see comments).  Hypertension. 1997;  29 111-114
    PubMedGoogle Scholar
  • 33 Ferrannini E, Wahren J, Faber O K, Felig P, Binder C, DeFronzo R A. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.  Am J Physiol. 1983;  244 E517-E527
    PubMedGoogle Scholar
  • 34 Lukaski H C, Bolonchuk W W, Hall C B, Siders W A. Validation of tetrapolar bioelectrical impedance method to assess human body composition.  J Appl Physiol. 1986;  60 1327-1332
    PubMedGoogle Scholar
  • 35 Svensson M, Yu Z W, Eriksson J W. A small reduction in glomerular filtration is accompained by insulin resistance in type 1 diabetes patients with diabetic nephropathy.  Eur J Clin Invest. 2002;  32 100-109
    CrossrefPubMedGoogle Scholar
  • 36 Wiggam M I, Hunter S J, Ennis C N, Sheridan B, Atkinson A B, Bell P M. Insulin action and skeletal muscle blood flow in patients with Type 1 diabetes and microalbuminuria.  Diabetes Res Clin Pract. 2001;  53 73-83
    CrossrefPubMedGoogle Scholar
  • 37 Bakris G, Weston W M, Rappaport E B, Freed M I. Rosiglitazone produces long-term reductions in urinary albumin excretion rate in type 2 diabetes.  Diabetologia. 1999;  42 A230
    PubMedGoogle Scholar
  • 38 Freed M I, Weston W M, Viberti G. Rosiglitazone reduces urinary albumin excretion in type 2 diabetes.  Diabetologia. 1999;  42 A230
    PubMedGoogle Scholar
  • 39 Ekstrand A V, Groop P H, Gronhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus.  Nephrol Dial Transplant. 1998;  13 3079-3083
    CrossrefPubMedGoogle Scholar

M. Svensson

Department of Medicine · Umeå University Hospital

901 85 Umeå · Sweden ·

Phone: + 46 (90) 785 25 86 (office)

Fax: + 46 (90) 14 39 86

Email: Maria.Svensson@medicin.umu.se

      >